PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 78 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $369,929 | -6.0% | 377,479 | -0.3% | 0.12% | -13.5% |
| Q4 2022 | $393,618 | -15.9% | 378,479 | -6.9% | 0.13% | -23.6% |
| Q3 2022 | $468,000 | -39.3% | 406,529 | -1.4% | 0.17% | -33.8% |
| Q2 2022 | $771,000 | -37.4% | 412,229 | +1.5% | 0.26% | -28.1% |
| Q1 2022 | $1,231,000 | -17.5% | 406,229 | +2.9% | 0.37% | -10.5% |
| Q4 2021 | $1,492,000 | -11.5% | 394,800 | +21.1% | 0.41% | +1.7% |
| Q3 2021 | $1,686,000 | – | 326,100 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |